Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Gains from Investment Securities (2018 - 2025)

Outset Medical (OM) has disclosed Gains from Investment Securities for 4 consecutive years, with $4.4 million as the latest value for Q1 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $4.4 million in Q1 2025 year-over-year; TTM through Dec 2025 was $4.4 million, a N/A change, with the full-year FY2025 number at $4.4 million, changed N/A from a year prior.
  • Gains from Investment Securities was $4.4 million for Q1 2025 at Outset Medical, up from -$528000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $4.4 million in Q1 2025 to a low of -$528000.0 in Q4 2023.